newsfilter
← Latest News
GlobeNewswire·

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

Strengthening CMC leadership to prepare for scaled up neflamapimod manufacturing On track to initiate Phase 3 trial of neflamapimod in DLB in mid-2026 following meeting with regulatory authorities BOSTON, June 10,